We develop breakthrough technologies to create the next generation of protein-based medicines
ProteoDesign, founded in 2012 as a spin-off from Princeton University, is currently based in the Barcelona Science Park and is committed to the development of new generation of protein therapeutics using proprietary conjugation technologies
ProteoDesign’s technology enables the development and production of a superior class of biotherapeutics, including antibody-drug conjugates, overcoming limitations of currently used methods.
Our mission is to improve patients’ quality of life by using our technological platform to develop novel biotherapeutics that deliver a superior efficacy with reduced side-effects.
- To contribute our scientific knowledge and expertise to the development of the biotechnological community
- To stimulate the continued improvement of the quality of our products and activities in order to provide real and consistent value to our partners, customers and end users.
- To offer an excellent service package that adds value and satisfies our global clients’ standards and demands.
- To identify interesting work opportunities in which ProteoDesign team members can professionally develop.
Professionalism, personal commitment, teamwork, individual progression, high level of training, innovation and creativity, efficiency, agility and integrity.